These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30501173)

  • 1. Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis.
    Early J; Ollinger J; Darby C; Alling T; Mullen S; Casey A; Gold B; Ochoada J; Wiernicki T; Masquelin T; Nathan C; Hipskind PA; Parish T
    ACS Infect Dis; 2019 Feb; 5(2):272-280. PubMed ID: 30501173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole cell screen for inhibitors of pH homeostasis in Mycobacterium tuberculosis.
    Darby CM; Ingólfsson HI; Jiang X; Shen C; Sun M; Zhao N; Burns K; Liu G; Ehrt S; Warren JD; Andersen OS; Brickner SJ; Nathan C
    PLoS One; 2013; 8(7):e68942. PubMed ID: 23935911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
    Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis.
    Early JV; Mullen S; Parish T
    PLoS One; 2019; 14(10):e0222970. PubMed ID: 31589621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-stress model for high throughput screening against non-replicating Mycobacterium tuberculosis.
    Gold B; Warrier T; Nathan C
    Methods Mol Biol; 2015; 1285():293-315. PubMed ID: 25779324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis.
    Gold B; Roberts J; Ling Y; Quezada LL; Glasheen J; Ballinger E; Somersan-Karakaya S; Warrier T; Warren JD; Nathan C
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6521-38. PubMed ID: 26239979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis.
    Mak PA; Rao SP; Ping Tan M; Lin X; Chyba J; Tay J; Ng SH; Tan BH; Cherian J; Duraiswamy J; Bifani P; Lim V; Lee BH; Ling Ma N; Beer D; Thayalan P; Kuhen K; Chatterjee A; Supek F; Glynne R; Zheng J; Boshoff HI; Barry CE; Dick T; Pethe K; Camacho LR
    ACS Chem Biol; 2012 Jul; 7(7):1190-7. PubMed ID: 22500615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Antimicrobials from Uncultured Bacteria Acting against Mycobacterium tuberculosis.
    Quigley J; Peoples A; Sarybaeva A; Hughes D; Ghiglieri M; Achorn C; Desrosiers A; Felix C; Liang L; Malveira S; Millett W; Nitti A; Tran B; Zullo A; Anklin C; Spoering A; Ling LL; Lewis K
    mBio; 2020 Aug; 11(4):. PubMed ID: 32753498
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model.
    Grant SS; Kawate T; Nag PP; Silvis MR; Gordon K; Stanley SA; Kazyanskaya E; Nietupski R; Golas A; Fitzgerald M; Cho S; Franzblau SG; Hung DT
    ACS Chem Biol; 2013 Oct; 8(10):2224-34. PubMed ID: 23898841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Phenotypically Tolerant Mycobacterium tuberculosis.
    Gold B; Nathan C
    Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28233509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput screening of compounds library to identify novel inhibitors against latent Mycobacterium tuberculosis using streptomycin-dependent Mycobacterium tuberculosis 18b strain as a model.
    Sharma S; Bhat R; Singh R; Sharma S; Wazir P; Singh PP; Vishwakarma RA; Khan IA
    Tuberculosis (Edinb); 2020 Sep; 124():101958. PubMed ID: 32791471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.
    Speer A; Shrestha TB; Bossmann SH; Basaraba RJ; Harber GJ; Michalek SM; Niederweis M; Kutsch O; Wolschendorf F
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1089-91. PubMed ID: 23254420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.
    Rodrigues Felix C; Gupta R; Geden S; Roberts J; Winder P; Pomponi SA; Diaz MC; Reed JK; Wright AE; Rohde KH
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
    Goldman RC
    Tuberculosis (Edinb); 2013 Nov; 93(6):569-88. PubMed ID: 24119636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Small-Molecule Inhibitor of the
    Sukheja P; Kumar P; Mittal N; Li SG; Singleton E; Russo R; Perryman AL; Shrestha R; Awasthi D; Husain S; Soteropoulos P; Brukh R; Connell N; Freundlich JS; Alland D
    mBio; 2017 Feb; 8(1):. PubMed ID: 28196957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis.
    Ollinger J; Kumar A; Roberts DM; Bailey MA; Casey A; Parish T
    PLoS One; 2019; 14(1):e0205479. PubMed ID: 30650074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.
    Berube BJ; Parish T
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
    ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.